Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Roche Holding AG Basel American Depositary Shares (OP: RHHBY )

44.56 USD +0.61 (+1.39%)
Official Closing Price Updated: 4:00 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Roche Holding AG Basel American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9
...
96 97 Next >
Bimbo 3
The US stock indexes today are all in the black. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Invitae Nabs Bristol Myers Squibb, J&J, Novartis, and Roche for Acute Myeloid Leukemia Project
Those are some solid endorsements. 
Tags NVS BMY NVTA
From Motley Fool
Regeneron To Supply US With Another 1.25M COVID-19 Treatment Doses
Biotech company Regeneron Pharmaceuticals Inc (NASDAQ: REGN) announced the signing of a $2.625 billion supply agreement with the U.S. ... 
Tags Antibodies Market News Events
From Benzinga
Pharma And Religion
Tuesday saw Wall Street anxious to avoid a second down day in a row despite politics and health issues. 
Tags Stocks / Equities
From Blogs - TalkMarkets
The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags FDA BGNE KLDO
From Benzinga
Here's Why Sarepta Therapeutics Lost Support on Wall Street
Disappointing trial results caused a flock of analysts to drop their ratings on this biotech stock. 
Tags RHHBY SRPT JPM
From Motley Fool
What's Next
Today I got a promotional mail reading” “What's next?” -- particularly appropriate today after yesterday's events disarray including the still buoyant stock market. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Moderna Hires Amgen Executive As Chief Commercial Officer To Bolster Vaccine Marketing
Moderna Inc (NASDAQ: MRNA), which received the fourth regulatory nod for its investigational coronavirus vaccine with the conditional ... 
Tags General SNY RHHBY
From Benzinga
This Small Gene Therapy Stock Is Taking On Giants Regeneron, Roche
Regenxbio launched a key study of its eye disease-targeting gene therapy, prompting RGNX stock to pop on Wednesday. It's also planning to test a gene therapy in muscular dystrophy. 
From Investor's Business Daily
This Small Gene Therapy Stock Is Taking On Giants Regeneron, Roche
Regenxbio launched a key study of its eye disease-targeting gene therapy, prompting RGNX stock to pop on Wednesday. It's also planning to test a gene therapy in muscular dystrophy. 
From Investor's Business Daily
RHHBY Makes Notable Cross Below Critical Moving Average
In trading on Wednesday, shares of Roche Hldg Ltd (RHHBY) crossed below their 200 day moving average of $43.22, changing hands as low as $42.78 per share. Roche Hldg Ltd shares are currently trading... 
Tags Stocks
From Market News Video
The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SLN GBIO DMAC
From Benzinga
3 Recession-Proof Healthcare Stocks to Buy for 2021
These stocks can handle whatever the new year has in store. 
Tags REGN SNY ABT
From Motley Fool
Genentech’s Novel Anti-TIGIT Tiragolumab Granted FDA Breakthrough Therapy Designation in Combination With Tecentriq for PD-L1-High Non-Small Cell Lung Cancer
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that tiragolumab, a novel cancer immunotherapy designed to bind to TIGIT, has been granted Breakthrough Therapy... 
From Business Wire News Releases
The Week Ahead In Biotech (Dec. 27-Jan. 2): Data Releases, Regulatory Filings To Move Stocks
Biotech stocks advanced for a fifth straight week in thin holiday trading. The gains, however, were more modest amid worries concerning the emergence of a new strain of coronavirus in the U.K. 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Week In Review: How Trump's Policies Moved Stocks -Saturday, Dec. 26
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump and his administration with this weekly... 
Tags Capital & Industrial Goods Energy Stocks / Equities
From Blogs - TalkMarkets
The Week Ahead In Biotech (Dec. 27-Jan. 2): Data Releases, Regulatory Filings To Move Stocks
Biotech stocks advanced for a fifth straight week in thin holiday trading. The gains, however, were more modest amid worries concerning ... 
Tags CARA Small Cap MITO
From Benzinga
Stock Market Risks
Pfizer is supplying another 100 milion doses to the US and will deliver vaccines to Mexico by Dec. 23. 
Tags Stocks / Equities
From Blogs - TalkMarkets
The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags BBIO SUPN SYRS
From Benzinga
Windsor Tour
Mercado Libre was raised two levels from hold to buy by Santander with a TP of $1980 today. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Vertex Pharmaceuticals Enters New Partnership With RNA Expert Skyhawk Therapeutics
The large biotech firm is just the latest deep-pocketed player to ink a heavily backloaded deal with the RNA-splicing specialist. 
Tags Market News VRTX RHHBY
From Motley Fool
Genentech’s Faricimab Meets Primary Endpoint and Shows Strong Durability Across Two Global Phase III Studies for Diabetic Macular Edema, a Leading Cause of Blindness
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) today announced positive topline results from two identically designed global Phase III studies, YOSEMITE and RHINE, evaluating its... 
From Business Wire News Releases
Better Coronavirus Stock: Pfizer vs. BioNTech
One healthcare company is confident about its future while the other tries to recapture its former glory. 
Tags Market News PFE VTRS
From Motley Fool
3 Top Biotech Stocks to Buy Right Now
Each of them should enjoy strong sales growth in 2021 and beyond. 
Tags BMY CRSP Market News
From Motley Fool
Data Show Which OTC Companies Traders Are Flocking To
Trading activity on OTC Markets spiked hard in November, reflecting the frenzied state of markets as investors reacted to the ... 
Tags AYRSF HRVSF CRLBF
From Benzinga
The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags KRBP SMTI GLPG
From Benzinga
12 Emerging Technologies To Watch In 2021
Technology stocks have historically led market rallies, and this year has been no exception. The Technology Select Sector SPDR Fund ... 
Tags UBER BIDU ADBE
From Benzinga
Up 60% In 2020, Here's Why DexCom Is Just Getting Started
This healthcare technology company is disrupting the diabetes market with innovative technologies that patients love. 
Tags Market News AAPL DXCM
From Motley Fool
Distillate Capital ETFs Launches Stability & Value ETF, ‘DTSX’
On Tuesday, Distillate Capital ETFs, a company whose funds are designed to provide long-term investors with superior after-fee returns, announced the launch of the Distillate International Fundamental... 
Tags KRX DSTX NSRGY
From ETF Trends
China Not Looking Good
China's local bond market has total debt equal to $4 bn and the risk to the regime for its failure is great. 
Tags Stocks / Equities
From Blogs - TalkMarkets
< Previous 1 2 3 4 5 6 7 8 9
...
96 97 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.